| Previous close | 1.3000 |
| Open | 1.3000 |
| Bid | 0.2000 |
| Ask | 5.0000 |
| Strike | 150.00 |
| Expiry date | 2024-11-15 |
| Day's range | 1.3000 - 1.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
Business WireCharles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
WILMINGTON, Mass., May 02, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its reference materials for adeno associated virus (AAV) and lentiviral vector (LVV) portfolio, designed to streamline Cell and Gene Therapy (CGT) research and development as it scales to Good Manufacturing Practice- (GMP) quality.
ZacksICLR vs. CRL: Which Stock Is the Better Value Option?
ICLR vs. CRL: Which Stock Is the Better Value Option?
ZacksCharles River (CRL) to Report Q1 Earnings: Here's What to Expect
Growth across Microbial Solutions and Biologics Testing businesses is likely to have contributed to Charles River's (CRL) Q1 revenues, offset by lower sales volume in the small model business.
© 2024 Yahoo. All rights reserved.